Clicky

A miniature heart in a Petri dish: an organoid emulates human heart development

A team at the Technical University of Munich (TUM) has induced stem cells to emulate the development of the human heart. The result is a kind of “mini-heart” known as an organoid. It will make it possible to study the earliest stages of our heart’s development and will facilitate research on diseases.

The human heart begins to form about three weeks after conception. This places the initial phase of heart development at a time when women are often not yet aware of their pregnancy. This is one of the reasons why we still know little about many details of how the heart forms. Results from animal studies are not fully transferable to humans. An organoid developed at TUM could be helpful to researchers.

A ball of 35,000 cells

The team working with Alessandra Moretti, professor of regenerative medicine in cardiovascular disease, has developed a method for creating a kind of “mini-heart” using pluripotent stem cells. About 35,000 cells are spun into a sphere in a centrifuge. Over a period of several weeks, various signaling molecules are added to the cell culture according to a fixed protocol. “In this way, we mimic the body’s signaling pathways that control the heart’s developmental program,” explains Alessandra Moretti. The group has published its work in the journal Nature Biotechnology.
The first-ever “epicardioids”

The resulting organoids are about half a millimeter in diameter. Although they do not pump blood, they can be stimulated electrically and are able to contract like human heart chambers. Professor Moretti and her team are the first researchers in the world to successfully create an organoid containing both heart muscle cells (cardiomyocytes) and cells from the outer layer of the heart wall (epicardium). In the young history of heart organoids – the first were described in 2021 – researchers had previously created only organoids with cardiomyocytes and cells from the inner layer of the heart wall (endocardium).

“To understand how the heart forms, the cells of the epicardium are decisive,” says Dr. Anna Meier, first author of the study. “Other cell types in the heart form from these cells, for example in connective tissue and blood vessels. The epicardium also plays a very important role in the formation of the heart chambers.” The team named the new organoids “epicardioids”.

A new cell type discovered

In addition to the method for producing the organoids, the team has made its first new discoveries. Through single-cell analysis, it determined that precursor cells of a type only recently discovered in mice form around the seventh day of the organoid’s development. The epicardium forms from these cells. “We assume that these cells also exist in the human body, even if only for a few days,” says Moretti.

This knowledge may also offer clues as to why the fetal heart can repair itself, an ability almost entirely absent in the heart of an adult. This knowledge could help find new methods of treatment for heart attacks and other conditions.

Producing “personalized organoids”

The team also showed that the organoids can be used to study the diseases of individual patients. Using pluripotent stem cells from a patient with Noonan syndrome, the researchers produced organoids that emulated the characteristics of the condition in a Petri dish. In the coming months the team plans to use similar personalized organoids to study other congenital heart defects.

Thanks to the possibility of emulating heart conditions in organoids, in the future drugs could be tested directly on them. “It is conceivable that such tests could reduce the need for animal experiments in drug development,” says Alessandra Moretti.

Organoid research is a key research area at TUM

The researchers have filed an international patent for the process of creating heart organoids. The Epicardioid model is one of several TUM organoid projects. At the Center for Organoid Systems, working groups from various departments and chairs will collaborate. They will conduct interdisciplinary research on pancreas, brain and heart organoids with cutting-edge cellular and imaging analyses to study organ formation, cancer and neurodegenerative diseases, and to achieve advances for medicine with human 3D systems.

Cosa vuoi trovare?